Tumor cell interactions with ECM molecules lead to clustering of integrins and activation of intracellular signaling pathways through the focal adhesion kinase (FAK), integrin-linked kinase (ILK) and Src kinase [32]. The gene discussed is PTK2; the disease is neoplasm.